These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27586019)

  • 1. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir.
    Garg B; Katare OP; Beg S; Lohan S; Singh B
    Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
    Patel G; Shelat P; Lalwani A
    Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
    Pham K; Li D; Guo S; Penzak S; Dong X
    J Control Release; 2016 Mar; 226():88-97. PubMed ID: 26849919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
    Ravi PR; Vats R; Dalal V; Murthy AN
    J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
    Kenechukwu FC; Dias ML; Ricci-Júnior E
    Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance.
    Beg S; Sandhu PS; Batra RS; Khurana RK; Singh B
    Drug Deliv; 2015; 22(6):765-84. PubMed ID: 24673611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir.
    Jain S; Sharma JM; Jain AK; Mahajan RR
    Nanomedicine (Lond); 2013 Oct; 8(10):1639-55. PubMed ID: 23351133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
    Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
    Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
    Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
    Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
    Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
    Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
    Zhang X; Wang H; Zhang T; Zhou X; Wu B
    Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug.
    Nassar T; Rohald A; Naraykin N; Barasch D; Amsalem O; Prabhu P; Kotler M; Benita S
    J Drug Target; 2019; 27(5-6):590-600. PubMed ID: 30470150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel bicephalous heterolipid based self-microemulsifying drug delivery system for solubility and bioavailability enhancement of efavirenz.
    Chaudhari KS; Akamanchi KG
    Int J Pharm; 2019 Apr; 560():205-218. PubMed ID: 30742985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.